GX LL7
Generic Name: fosamprenavir
Pill imprint GX LL7 has been identified as Lexiva 700 mg.
Lexiva is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy.
Lexiva 700 mg is not subject to the Controlled Substances Act.
See also related documents.
Lexiva Images
- Generic Name:
- fosamprenavir
- Imprint:
-
GX LL7
- Strength:
- 700 mg
- Color:
- Pink
- Size:
- 21.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
povidone k30
hypromellose
titanium dioxide
triacetin
ferric oxide red
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0721
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4954 | Physicians Total Care Inc (repackager) |
| 54569-5550 | A S Medication Solutions LLC (repackager) |
| 35356-0067 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Lexiva resources
Search Again
